A basal-bolus insulin regimen pairs a once- or twice-daily long-acting insulin with a rapid-acting insulin at each meal — the closest manual approximation to how a healthy pancreas releases insulin. It is the gold standard for type 1 diabetes and is used in type 2 diabetes when other regimens cannot reach glucose targets. Total daily dose typically starts at 0.4 to 0.7 units per kg in type 2 and 0.5 to 1.0 units per kg in type 1, split roughly 50 percent basal and 50 percent bolus. The trade-off is complexity — 4 or more injections per day, plus carb-aware meal dosing — in exchange for the lowest achievable A1C with injection therapy and the most flexibility around meals.
What “Basal-Bolus” Means
A healthy pancreas secretes insulin in two modes:
- Basal — a steady, low background release between meals and overnight that suppresses hepatic glucose output and keeps fasting glucose stable.
- Bolus — a rapid surge after a meal that pushes glucose into muscle and fat as carbohydrates absorb.
A basal-bolus insulin regimen mimics this with two injected products — a long-acting basal analog given once or twice daily, plus a rapid-acting bolus analog given before each meal. The result is a flexible, physiologic profile that supports near-normal glucose control when adjusted carefully.
Which Insulins Are Used
| Role | Common Insulins | Onset | Duration |
|---|---|---|---|
| Basal — once daily | Glargine U-100, U-300, Degludec, Detemir (sometimes) | 1–2 h | 20–42 h |
| Basal — twice daily | Detemir, NPH (older), Levemir | 1–2 h | 12–24 h |
| Bolus — rapid analog | Lispro, Aspart, Glulisine | 10–15 min | 3–5 h |
| Bolus — ultra-rapid | Fiasp, Lyumjev | 2–5 min | 3–5 h |
| Bolus — inhaled | Afrezza | 1–3 min | 1.5–3 h |
| Bolus — regular (legacy) | Humulin R, Novolin R | 30–60 min | 5–8 h |
For a head-to-head on basal options, see insulin degludec vs. glargine. For all insulin categories at a glance, see our insulin types comparison.
Calculating a Starting Regimen
- Total Daily Dose (TDD) — body weight in kg multiplied by a starter factor: 0.4 to 0.5 u/kg for insulin-naive type 2 diabetes; 0.5 to 1.0 u/kg for type 1 diabetes. Reduce by 20 percent for elderly, renal insufficiency, or honeymoon-phase T1D.
- Split 50/50 — half of TDD as basal, half as bolus.
- Divide bolus across meals — equal thirds is a common starting point; you can also weight by typical meal carb content (e.g., 40 percent breakfast, 30 percent lunch, 30 percent dinner).
- Set Insulin-to-Carb Ratio (I:C) — using the 500 Rule: 500 divided by TDD. Used to refine bolus per actual meal carb count.
- Set Correction Factor (CF) — using the 1800 Rule for rapid analogs: 1800 divided by TDD. Used to add correction units when premeal glucose is above target.
Worked Example
| Parameter | Value | How Derived |
|---|---|---|
| Weight | 80 kg | Patient |
| Diabetes type | Type 2, insulin-naive | Clinical |
| Starting factor | 0.5 u/kg | Mid-range starter |
| TDD | 40 units | 80 × 0.5 |
| Basal dose | 20 units (glargine bedtime) | 50% of TDD |
| Bolus split | 7 / 7 / 6 units (B/L/D) | Even thirds of 20 |
| I:C ratio | 1:12.5 (round to 1:13) | 500 / 40 |
| Correction factor | 45 mg/dL per unit | 1800 / 40 |
| Premeal target | 100 mg/dL | ADA guideline |
With those parameters, a meal of 60 g carbs at premeal BG 160 mg/dL would be: bolus = 60 / 13 = 4.6, rounded to 5 units. Correction = (160 − 100) / 45 = 1.3, rounded to 1 unit. Total = 6 units before the meal.
Titration After Starting
- Basal — adjust based on fasting morning glucose. ADA “2-by-3” protocol: increase basal by 2 units every 3 days until morning glucose 80 to 130 mg/dL. Reduce by 10 to 20 percent if any morning hypoglycemia.
- Bolus — adjust based on 2-hour post-meal glucose. Target less than 180 mg/dL post-prandial.
- I:C and CF — refine over weeks using paired glucose data and structured carb tracking.
- Frequency — most adjustments happen every 2 to 4 weeks initially, less often once at target.
Use carb counting and the correction factor framework together for tightest control.
Pros and Cons
| Pros | Cons |
|---|---|
| Best achievable A1C with injections | 4 or more injections per day |
| Eat when and what you want (with carb counting) | Cognitive burden of math at every meal |
| Adjust basal and bolus independently | Hypoglycemia risk from miscalculation |
| Standard of care for T1D | More supplies, more cost than premix |
| Easy to layer on CGM and pump later | Requires structured education |
How Basal-Bolus Compares With Other Regimens
| Regimen | Daily Injections | Flexibility | Typical A1C Improvement |
|---|---|---|---|
| Basal alone (T2D start) | 1 | Low | 1.5–2.0% |
| Premix 70/30 twice daily | 2 | Low–medium | 1.5–2.0% |
| Basal + 1 bolus (basal-plus) | 2 | Medium | 1.7–2.2% |
| Full basal-bolus | 4+ | High | 1.8–2.5% |
| Insulin pump | 0 (one cannula change every 2–3 days) | Highest | 2.0–3.0% |
Evidence Base
Intensive basal-bolus therapy demonstrated landmark reductions in microvascular complications in the DCCT trial in type 1 diabetes — 76 percent reduction in retinopathy progression compared with conventional 1 to 2 injections per day. UKPDS 33 showed comparable benefit for intensified insulin therapy in type 2 diabetes. Modern analogs and CGM have further improved the safety and ease of basal-bolus.
For details, see the DCCT primary publication (NEJM 1993) and the ADA Standards of Care 2024.
Common Mistakes and How to Avoid Them
- Stacking corrections — giving a correction within 3 hours of the last rapid bolus stacks active insulin and causes hypoglycemia. Use the “active insulin time” rule.
- Skipping meals after bolusing — never inject rapid analog and then delay or skip the meal.
- Static doses — failing to adjust I:C and CF over months as weight, activity, or sensitivity changes.
- Poor site rotation — creates lipohypertrophy and erratic absorption.
- Cold insulin — injecting straight from the fridge stings and slightly delays onset.
Side Effects of the Regimen as a Whole
- Hypoglycemia — most common; risk highest at peak of each bolus and overnight from basal
- Weight gain of approximately 2 to 4 kg in first 6 to 12 months
- Injection site reactions; lipohypertrophy with poor rotation
- Hypokalemia, especially in hospitalized or diuretic-treated patients
- Rare anaphylaxis
- Burnout — common after years of multiple daily decisions; addressed with team support and tech upgrades
Who Should Use Basal-Bolus
- All adults and children with type 1 diabetes (unless using a pump)
- Type 2 diabetes with A1C above target on premix or maximal non-insulin therapy
- Gestational diabetes when diet plus oral or basal alone is insufficient
- Hospitalized patients with type 2 diabetes (often basal-bolus plus correction in inpatient setting)
- Anyone wanting maximum mealtime flexibility
Always pair with a structured education program — DAFNE, BERTIE, or local diabetes-education curricula — and ideally a continuous glucose monitor for safe titration.
The Bottom Line
A basal-bolus insulin regimen pairs a once-daily long-acting analog with a rapid analog at each meal — the most physiologic injection-based therapy available. Starting TDD is roughly 0.4 to 0.7 u/kg in type 2 and 0.5 to 1.0 u/kg in type 1, split 50/50 between basal and bolus. The regimen offers the best achievable A1C and meal flexibility in exchange for 4 or more injections per day plus correction-factor and carb-counting math. Hypoglycemia is the main risk, mitigated by careful stacking rules, CGM, and structured education. It is the standard of care for type 1 diabetes and the next step for type 2 when other regimens fall short.
